Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Panacea enters agreements with Loyola covering Lewy body disorders

June 29, 2000

Riluzole + alpha-tocopherol delays progression of ALS more frequently than riluzole alone

June 28, 2000

BASF joins in search for therapeutically useful PARP inhibitors

June 28, 2000

SM-31900 emerges as a promising therapeutic for stroke

June 28, 2000

Estrogen fails to alter cognition, mood or cerebral blood flow in Alzheimer's patients

June 28, 2000

Neurocrine Biosciences presents new CRF receptor antagonists

June 27, 2000

BMS synthesizes nonimmunosuppressive neurotrophic agents

June 27, 2000

New phospholipase A2 inhibitors presented by Elan in patent literature

June 26, 2000

Novel neuroprotective compounds exert NMDA-activating, AMPA-inhibiting effects

June 26, 2000

Extended-release venlafaxine proven safe and effective for the treatment of GAD

June 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...